The pharmaceutical industry faces a perfect storm, with unsustainable growth in healthcare costs, increasing costs of drug discovery, and the shift to a value-based payment model.
The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course better revenues for pharma are all possible.